Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades.

Mohansrinivas ChennakesavaluCaileigh PudelaMark A ApplebaumSang Mee LeeYan CheArlene NaranjoJulie R ParkSamuel L VolchenboumTara O HendersonSusan L CohnAmi V Desai

Published in: EJC paediatric oncology (2023)

Racial/ethnic survival disparities have persisted over time and were observed among high-risk patients assigned to receive post-Consolidation dinutuximab.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
free survival
affordable care act
health insurance